The Scientist at 15

This issue, Oct. 29, 2001, marks the beginning of the 16th year of publication of The Scientist. It is remarkable and sobering to look back over these relatively few years and to see how much has changed in the landscape of science, and even more remarkable how many things have stayed the same. Public awareness of the life sciences has dramatically increased. Stem cell research, the human genome project, and now the grisly threat of bioterrorism mean that life scientists are now more than ever i

Written byAlexander Grimwade
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The first issue of The Scientist, published on Oct. 20, 1986, covered a story on the appointment of William Graham as presidential science advisor after a nine-month search. Today, after 10 months of the Bush presidency, the appointment of James Marbuger as Director of the Office of Science and Technology Policy is as yet unconfirmed. Both then and now, science, though recognized as one of the key engines of the economic strength of this country, still lacks the political clout that it surely deserves and requires.

Also in our first issue was a salary survey that concluded that the median salary for research scientists was between $50,000 and $60,000 per year. Our recent, much larger survey found a median salary for life scientists of $55,000. (The Scientist, 15[18]:30 Sept. 17, 2001). Admittedly there are differences in sample and methodology, but nevertheless, the lack of progress in 15 years is striking.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies